Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 05 Apr 2023
According to new research, the recurrence of prostate cancer following radiotherapy can be accurately predicted by two important proteins connected to cell division.
Read Full NewsA retrospective study evaluates outcomes associated with first-line enfortumab vedotin plus pembrolizumab vs gemcitabine plus cisplatin in patients with metastatic urothelial carcinoma.
For women with invasive lobular carcinoma, pathogenic variants in breast cancer risk genes predict high odds of early recurrence.
Higher background parenchymal enhancement on breast MRI may signal greater risk among women who carry BRCA mutations.
Patients with relapsed or refractory diffuse large B-cell lymphoma, who were ineligible for autologous stem cell transplant, were randomly assigned to receive Pola-R-GemOx or R-GemOx.
1.
WHO Warns Loosely Regulated Nicotine Pouches Risk Youth Addiction
2.
Novel Treatment Shows Promise for Oral Mucositis Caused by Radiation.
3.
Study finds higher breast cancer rates in areas with more air pollution
4.
Having a tattoo could increase your risk of developing lymphoma.
5.
Nanoparticle vaccine prevents multiple cancers and stops metastasis in mice
1.
The Lowdown on Darbepoetin: Understanding Its Uses and Side Effects
2.
Deep Learning Fluorescence Imaging for Oral Cancer Surgery: In Silico Depth Quantification
3.
Surgery for Tracheoesophageal Fistula: What to Expect Before, During, and After
4.
Exploring the Latest Advances in PTLD Cancer Treatment
5.
All You Need To Know About Cancer Antigen 27-29: Causes, Symptoms & Treatment
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- The Conclusion
2.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part V
3.
An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Q & A Session
4.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part IV
5.
Navigating the Complexities of Ph Negative ALL - Part XI
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge